Message to Shareholders | Consolidated Financial Highlights | Mission and Vision | Macroeconomic Environment | Commercial Division
Treasury and Capital Markets | Operating Results | Exports by Country | Social Development | Bladex’s Team
Board of Directors | Shareholders | Management Committee | Executive Staff | Regional Offices | Financial Statements
Consolidated Financial Highlights
12
YEAR ENDED DECEMBER 31
2006
2007
(In US$ million, except per share amounts)

Income Statement Data
Net Interest Income
59
71
Provision for credit losses
13
1
Fees and Commisions, net
6
6
Operating Expenses
(29)
(37)
Net Income
58
72
Balance Sheet Data
Loan and investment portfolio, net of unearned income and deferred loan fees (1)
3,448
4,194
Credit Portfolio, net of unearned income (2)
4,001
4,747
Total Assets
3,978
4,791
Total Liabilities
3,394
4,178
Stockholders' Equity
584
612
Net income per share (US$)
1.56
1.99
Book value per Common Share
-period end- (US$)
16.07
16.83
Common Shares Outstanding: (in thousands)
Period average
37,065
36,349
Period end
36,329
36,370

SELECTED FINANCIAL RATIOS (In %)
 
Return on average assets
1.70
1.71
Return on average stockholders' equity
10.0
11.9
Net interest margin
1.76
1.71
Total operating expenses to total average assets
0.85
0.88
Non-accruing loans and investments to
total loan and selected investment portfolio (1)
0.00
0.00
Allowance for loan losses to total loan portfolio (1)
1.72
1.87
Allowance for losses on off-balance sheet credit risk to total contingencies
4.18
2.48
Stockholders' equity to total assets
14.7
12.8
Tier 1 capital to risk-weighted assets
24.4
20.9
Total capital to risk-weighted assets
25.7
22.2
Notes
(1) Loan portfolio is presented net of unearned income and deferred loans fees.
(2) Includes book value of loans, fair value of investment securities, acceptances, and contingencies, (including confirmed letters of credit, stand-by letters of credit, reimbursement undertakings and guarantees covering commercial and country risks, credit default swaps and credit commitments).